# OnCo record men1703 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/men1703/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "men1703" ;
  schema:name "MEN1703"@en ;
  schema:alternateName "Dapolsertib hydrochloride"@en ;
  schema:description "MEN1703 is an experimental small molecule (kinase inhibitor) from Ryvu Therapeutics in phase 2 trials for hodgkin lymphoma, aimed at FLT3."@en ;
  schema:url <https://onco.cc/drugs/men1703/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=SEL24>, <https://www.ryvu.com> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule (kinase inhibitor)" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:targets <https://onco.cc/targets/flt3/> ;
  onco:companies <https://onco.cc/companies/ryvu-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06534437/> .